Active Clinical Trials
Cardiothoracic Surgery Clinical Trials |
|---|
|
A Facilitated Access Program to Provide Everolimus (RAD) Maintenance for Patients Completing Therapy in RAD Trials in Solid Organ Transplantation Principal Investigator(s): Takushi Kohmoto, MD, PhD Status: Active, not recruiting [ClinicalTrials.gov: NCT00149981] More Information |
|
Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) Principal Investigator(s): Takushi Kohmoto, MD, PhD Status: Recruiting [ClinicalTrials.gov: NCT00119834] More Information |
General Surgery Clinical Trials |
|---|
|
A Phase III Study of Chemotherapy and Chemoradiotherapy With or Without HyperAcute®-Pancreas (Algenpantucel-L) Immunotherapy in Subjects With Surgically Resected Pancreatic Cancer Principal Investigator(s): Clifford S Cho, MD Status: Recruiting [ClinicalTrials.gov: NCT01072981] More Information |
|
An Open-Label, Controlled, Randomized, Multicenter, Dose Escalation Study Evaluating the Safety and Efficacy of StrataGraft® Skin Tissue in Promoting the Healing of the Deep Partial-Thickness Component of Complex Skin Defects as an Alternative to Autografting Principal Investigator(s): Lee D Faucher, MD Status: Recruiting [ClinicalTrials.gov: NCT01437852] More Information |
|
A Phase III Prospective Randomized Trial Comparing Laparoscopic-assisted Resection Versus Open Resection for Rectal Cancer Principal Investigator(s): Gregory D Kennedy, MD, PhD Status: Recruiting [ClinicalTrials.gov: NCT00726622] More Information |
|
Phase III Study on the Efficacy of Glutamine Dipeptide-Supplemented Parenteral Nutrition in Surgical ICU Patients Principal Investigator(s): Kenneth Allan Kudsk, MD Status: Recruiting [ClinicalTrials.gov: NCT00248638] More Information |
|
A Phase III Multicenter Randomized Trial of Sentinel Lymphadenectomy and Complete Lymph Node Dissection Versus Sentinel Lymphadenectomy Alone in Cutaneous Melanoma Patients With Molecular or Histopathological Evidence of Metastases in the Sentinel Node Principal Investigator(s): Heather B Neuman, MD, MS Status: Recruiting [ClinicalTrials.gov: NCT00297895] More Information |
|
A Phase II Study of Preoperative Gemcitabine and Erlotinib Plus Pancreatectomy and Postoperative Gemcitabine and Erlotinib for Patients With Operable Pancreatic Adenocarcinoma Principal Investigator(s): Sharon M Weber, MD Status: Recruiting [ClinicalTrials.gov: NCT00733746] More Information |
|
A Prognostic Study of Sentinel Node and Bone Marrow Micrometastases in Women With Clinical T1-2 N0 Breast Cancer Principal Investigator(s): Sharon M Weber, MD Status: Active, not recruiting [ClinicalTrials.gov: NCT00003854] More Information |
|
A Randomized, Open Label, Parallel-group, Multi-center Trial to Compare the Efficacy and Safety of TachoSil® Versus Surgicel® Original for the Secondary Treatment of Local Bleeding in Adult and Pediatric Patients Undergoing Hepatic Resection Surgery Principal Investigator(s): Sharon M Weber, MD Status: Recruiting [ClinicalTrials.gov: NCT01192022] More Information |
|
A Randomized Trial of Axillary Node Dissection in Women With Clinical T1-2 N0-1 M0 Breast Cancer Who Have a Positive Sentinel Node Principal Investigator(s): Sharon M Weber, MD Status: Active, not recruiting [ClinicalTrials.gov: NCT00003855] More Information |
Otolaryngology-Head & Neck Surgery Clinical Trials |
|---|
|
The Effect of Overnight Use of Electroacustimulation on Postoperative Nausea and Vomiting in the Outpatient Surgery Population Principal Investigator(s): Benjamin C Marcus, MD Status: Recruiting [ClinicalTrials.gov: NCT01394536] More Information |
|
The Utility of Peri-operative Arnica Montana for Reduction of Ecchymosis in Rhinoplasty Surgery Principal Investigator(s): Benjamin C Marcus, MD Status: Recruiting [ClinicalTrials.gov: NCT01164644] More Information |
|
Phase IIB Randomized, Placebo Controlled Trial of Pioglitazone for Oral Premalignant Lesions An Inter-Consortium Collaborative Study Principal Investigator(s): Timothy M McCulloch, MD Status: Recruiting [ClinicalTrials.gov: NCT00951379] More Information |
Transplantation Clinical Trials |
|---|
|
DSR-guided Tacrolimus Withdrawal to Myfortic Monotherapy in Liver Transplantation Principal Investigator(s): William J Burlingham, PhD Status: Recruiting [ClinicalTrials.gov: NCT01230502] More Information |
|
Mycophenolic Acid Monotherapy in Recipients of HLA-identical Living-Related Transplantation Principal Investigator(s): William J Burlingham, PhD, Hans W. Sollinger, MD, PhD, FACS Status: Recruiting [ClinicalTrials.gov: NCT01053221] More Information |
|
A 24-month Randomized Multicenter Study Evaluating Efficacy, Safety, Tolerability and Pharmacokinetics of Sotrastaurin and Tacrolimus vs. a Tacrolimus/Mycophenolate Mofetil-based Control Regimen in de Novo Liver Transplant Recipients Principal Investigator(s): Anthony M D’Alessandro, MD Status: Recruiting [ClinicalTrials.gov: NCT01128335] More Information |
|
Calcineurin Inhibitor-free, Steroid-free Immunosuppressive Regimen in Simultaneous Islet-Kidney Transplantation for Uremic Type 1 Diabetic Patients Principal Investigator(s): Luis A Fernandez, MD Status: Recruiting [ClinicalTrials.gov: NCT01033500] More Information |
|
Controlled, Randomized, Prospective, Double-Blind, Multicenter, Phase I/II, Dose-Escalation Study of the Safety, PK, and Clinical Activity of I5NP for Prophylaxis of Delayed Graft Function in Patients Undergoing Deceased Donor Kidney Transplantation Principal Investigator(s): David P Foley, MD Status: Recruiting [ClinicalTrials.gov: NCT00802347] More Information |
|
Islet Transplantation in Type 1 Diabetic Patients Using a Steroid-free Immunosuppression Protocol and Thiazolidinedione Insulin Sensitizers Principal Investigator(s): Jon S Odorico, MD Status: Recruiting [ClinicalTrials.gov: NCT00214253] More Information |
|
A Phase 1b, Randomized, Double-Blind, Parallel Group, Placebo-Controlled, Single-Dose, Pharmacokinetic, Pharmacodynamic, Safety, and Tolerability Study of ASKP1240 in de Novo Kidney Transplantation Principal Investigator(s): John D Pirsch, MD Status: Active, not recruiting [ClinicalTrials.gov: NCT01279538] More Information |
|
Ph3,DB/DD,Multi-Ctr,Pros,Rand Study-Efficacy and Safety of LCP-Tacro™ Tablets, QD, Compared to Prograf® Capsules,BID, in Combination With Mycophenolate Mofetil for Acute Allograft Rejection in De Novo Kidney Transplant Principal Investigator(s): John D Pirsch, MD Status: Recruiting [ClinicalTrials.gov: NCT01187953] More Information |
|
A Partially Blinded, Prospective, Randomized Multicenter Study Evaluating Efficacy, Safety and Tolerability of Oral Sotrastaurin Plus Standard or Reduced Exposure Tacrolimus vs. Mycophenolic Acid Plus Tacrolimus in de Novo Renal Transplant Recipients Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS Status: Active, not recruiting [ClinicalTrials.gov: NCT01064791] More Information |
|
Recombinant Human C1 Inhibitor for the Treatment of Early Antibody-Mediated Rejection in Renal Transplantation Principal Investigator(s): Hans W. Sollinger, MD, PhD, FACS Status: Recruiting [ClinicalTrials.gov: NCT01035593] More Information |
|
Effect of Fluoroquinolones on BK Viremia in the Renal Transplant Recipient, A Multi-Center Study Status: Recruiting [ClinicalTrials.gov: NCT01034176] More Information |
|
Genomics of Chronic Renal Allograft Rejection Status: Active, not recruiting [ClinicalTrials.gov: NCT00611702] More Information |
Vascular Surgery Clinical Trials |
|---|
|
An Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for the Primary Treatment of Aneurysm of the Descending Thoracic Aortic Principal Investigator(s): Charles W Acher, MD Status: Active, not recruiting [ClinicalTrials.gov: NCT00874250] More Information |
|
A Phase 2, Randomized, Open-label (With Blinded Plasminogen Activator and Placebo Control Groups) Study to Evaluate the Effects of Different Intra-thrombus Infusion Regimens of Plasmin (Human) Compared to Plasminogen Activator and Placebo In Patients With Acute Lower Extremity Native Artery or Bypass Graft Occlusion Principal Investigator(s): John R Hoch, MD Status: Recruiting [ClinicalTrials.gov: NCT01222117] More Information |
|
Prospective, Multicenter, Randomized Controlled Trial of Endovascular Aneurysm Repair Using a Bilateral Percutaneous Approach (PEVAR) vs. Standard Approach (SEVAR) Using the IntuiTrak Endovascular AAA Delivery System and the Prostar XL or Perclose ProGlide Suture-Mediated Closure System Principal Investigator(s): Jon S Matsumura, MD Status: Enrolling by invitation [ClinicalTrials.gov: NCT01070069] More Information |
|
Carotid Angioplasty and Stenting Versus Endarterectomy in Asymptomatic Subjects Who Are at Standard Risk for Carotid Endarterectomy With Significant Extracranial Carotid Stenotic Disease (ACT I) Principal Investigator(s): Girma Tefera, MD Status: Recruiting [ClinicalTrials.gov: NCT00106938] More Information |
|
Carotid Stenting For High Surgical-Risk Patients; Evaluating Outcomes Through The Collection Of Clinical Evidence Principal Investigator(s): Girma Tefera, MD Status: Recruiting [ClinicalTrials.gov: NCT00406055] More Information |
|
Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Acute Complicated Type B Aortic Dissection Principal Investigator(s): Girma Tefera, MD Status: Enrolling by invitation [ClinicalTrials.gov: NCT00908388] More Information |
|
Evaluation of the GORE Conformable TAG® Thoracic Endoprosthesis for Treatment of Traumatic Transection of the Descending Thoracic Aorta Principal Investigator(s): Girma Tefera, MD Status: Enrolling by invitation [ClinicalTrials.gov: NCT00917852] More Information |
|
Prospective Aneurysm Trial: High Angle Aorfix™ Bifurcated Stent Graft Principal Investigator(s): Girma Tefera, MD Status: Recruiting [ClinicalTrials.gov: NCT00522535] More Information |
|
The Gore FREEDOM Study: GORE Flow Reversal System and GORE Embolic Filter Extension Study for the Ongoing Collection of Patient Outcomes Principal Investigator(s): Girma Tefera, MD Status: Recruiting [ClinicalTrials.gov: NCT01343667] More Information |